Compile Data Set for Download or QSAR
maximum 50k data
Found 85 Enz. Inhib. hit(s) with all data for entry = 50015975
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163221(4-(3-Trifluoromethyl-pyridin-2-yl)-piperazine-1-ca...)
Affinity DataKi:  38nMAssay Description:Displacement of [3H]resiniferatoxin from human Transient receptor potential vanilloid 1 receptor; (n=2)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163224(4-(3-Trifluoromethyl-pyridin-2-yl)-piperazine-1-ca...)
Affinity DataIC50:  3nMAssay Description:In vitro inhibition of PMA-activated human TRPV1 receptor in [Ca2+] influx assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163221(4-(3-Trifluoromethyl-pyridin-2-yl)-piperazine-1-ca...)
Affinity DataIC50:  3nMAssay Description:In vitro inhibition of anandamide activated human TRPV1 receptor in [Ca2+] influx assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163227(4-(2-Trifluoromethyl-phenyl)-piperazine-1-carboxyl...)
Affinity DataIC50:  3nMAssay Description:In vitro inhibition of acid activated rat TRPV1 receptor in [Ca2+] influx assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163221(4-(3-Trifluoromethyl-pyridin-2-yl)-piperazine-1-ca...)
Affinity DataIC50:  3nMAssay Description:In vitro inhibition of PMA-activated human TRPV1 receptor in [Ca2+] influx assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163227(4-(2-Trifluoromethyl-phenyl)-piperazine-1-carboxyl...)
Affinity DataIC50:  3nMAssay Description:In vitro inhibition of PMA-activated human TRPV1 receptor in [Ca2+] influx assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163221(4-(3-Trifluoromethyl-pyridin-2-yl)-piperazine-1-ca...)
Affinity DataIC50:  3nMAssay Description:In vitro inhibition of anandamide activated human TRPV1 receptor in [Ca2+] influx assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163224(4-(3-Trifluoromethyl-pyridin-2-yl)-piperazine-1-ca...)
Affinity DataIC50:  3nMAssay Description:In vitro inhibition of acid activated rat TRPV1 receptor in [Ca2+] influx assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM20284(CHEMBL391997 | CPZ | Capsazepine | N-[2-(4-chlorop...)
Affinity DataIC50:  4nMAssay Description:In vitro inhibition of acid activated rat TRPV1 receptor in [Ca2+] influx assayMore data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM20284(CHEMBL391997 | CPZ | Capsazepine | N-[2-(4-chlorop...)
Affinity DataIC50:  4nMAssay Description:In vitro inhibition of anandamide activated human TRPV1 receptor in [Ca2+] influx assayMore data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM20284(CHEMBL391997 | CPZ | Capsazepine | N-[2-(4-chlorop...)
Affinity DataIC50:  4nMAssay Description:In vitro inhibition of anandamide activated human TRPV1 receptor in [Ca2+] influx assayMore data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163224(4-(3-Trifluoromethyl-pyridin-2-yl)-piperazine-1-ca...)
Affinity DataIC50:  4nMAssay Description:In vitro inhibition of anandamide activated human TRPV1 receptor in [Ca2+] influx assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163221(4-(3-Trifluoromethyl-pyridin-2-yl)-piperazine-1-ca...)
Affinity DataIC50:  4nMAssay Description:In vitro inhibition of acid activated rat TRPV1 receptor in [Ca2+] influx assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163227(4-(2-Trifluoromethyl-phenyl)-piperazine-1-carboxyl...)
Affinity DataIC50:  4nMAssay Description:In vitro inhibition of anandamide activated human TRPV1 receptor in [Ca2+] influx assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163221(4-(3-Trifluoromethyl-pyridin-2-yl)-piperazine-1-ca...)
Affinity DataIC50:  5nMAssay Description:In vitro inhibition of anandamide activated human TRPV1 receptor in [Ca2+] influx assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM20284(CHEMBL391997 | CPZ | Capsazepine | N-[2-(4-chlorop...)
Affinity DataIC50:  5nMAssay Description:In vitro inhibition of PMA-activated human TRPV1 receptor in [Ca2+] influx assayMore data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM20284(CHEMBL391997 | CPZ | Capsazepine | N-[2-(4-chlorop...)
Affinity DataIC50:  5nMAssay Description:In vitro inhibition of PMA-activated human TRPV1 receptor in [Ca2+] influx assayMore data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163224(4-(3-Trifluoromethyl-pyridin-2-yl)-piperazine-1-ca...)
Affinity DataIC50:  6nMAssay Description:In vitro inhibition of anandamide activated human TRPV1 receptor in [Ca2+] influx assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163227(4-(2-Trifluoromethyl-phenyl)-piperazine-1-carboxyl...)
Affinity DataIC50:  6nMAssay Description:In vitro inhibition of anandamide activated human TRPV1 receptor in [Ca2+] influx assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163227(4-(2-Trifluoromethyl-phenyl)-piperazine-1-carboxyl...)
Affinity DataIC50:  6nMAssay Description:In vitro inhibition of anandamide activated human TRPV1 receptor in [Ca2+] influx assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163224(4-(3-Trifluoromethyl-pyridin-2-yl)-piperazine-1-ca...)
Affinity DataIC50:  6nMAssay Description:In vitro inhibition of anandamide activated human TRPV1 receptor in [Ca2+] influx assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163221(4-(3-Trifluoromethyl-pyridin-2-yl)-piperazine-1-ca...)
Affinity DataIC50:  57nMAssay Description:Inhibition of human transient receptor potential vanilloid 1 receptor (n=6)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163225(2-Methyl-4-(3-trifluoromethyl-pyridin-2-yl)-pipera...)
Affinity DataIC50:  64nMAssay Description:Inhibition of human transient receptor potential vanilloid 1 receptor (n=4)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163227(4-(2-Trifluoromethyl-phenyl)-piperazine-1-carboxyl...)
Affinity DataIC50:  65nMAssay Description:Inhibition of human transient receptor potential vanilloid 1 receptor (n=8)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163224(4-(3-Trifluoromethyl-pyridin-2-yl)-piperazine-1-ca...)
Affinity DataIC50:  74nMAssay Description:Inhibition of human transient receptor potential vanilloid 1 receptor (n=6)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM20284(CHEMBL391997 | CPZ | Capsazepine | N-[2-(4-chlorop...)
Affinity DataIC50:  74nMAssay Description:Inhibition of human transient receptor potential vanilloid 1 receptor (n=5)More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163221(4-(3-Trifluoromethyl-pyridin-2-yl)-piperazine-1-ca...)
Affinity DataIC50:  90nMAssay Description:Inhibition of rat transient receptor potential vanilloid 1 receptor (n=4)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163224(4-(3-Trifluoromethyl-pyridin-2-yl)-piperazine-1-ca...)
Affinity DataIC50:  100nMAssay Description:Inhibition of rat transient receptor potential vanilloid 1 receptor (n=3)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163227(4-(2-Trifluoromethyl-phenyl)-piperazine-1-carboxyl...)
Affinity DataIC50:  102nMAssay Description:Inhibition of rat transient receptor potential vanilloid 1 receptor (n=6)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163225(2-Methyl-4-(3-trifluoromethyl-pyridin-2-yl)-pipera...)
Affinity DataIC50:  104nMAssay Description:Inhibition of rat transient receptor potential vanilloid 1 receptor (n=4)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163218(4-(3-Methyl-pyridin-2-yl)-piperazine-1-carboxylic ...)
Affinity DataIC50:  113nMAssay Description:Inhibition of human transient receptor potential vanilloid 1 receptor (n=4)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163235(4-o-Tolyl-piperidine-1-carboxylic acid (4-trifluor...)
Affinity DataIC50:  175nMAssay Description:Inhibition of human transient receptor potential vanilloid 1 receptor (n=2)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163217(4-(3-Methyl-pyridin-2-yl)-piperazine-1-carboxylic ...)
Affinity DataIC50:  194nMAssay Description:Inhibition of rat transient receptor potential vanilloid 1 receptor (n=3)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163217(4-(3-Methyl-pyridin-2-yl)-piperazine-1-carboxylic ...)
Affinity DataIC50:  290nMAssay Description:Inhibition of human transient receptor potential vanilloid 1 receptor (n=3)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163216(4-(2-Trifluoromethyl-phenyl)-piperazine-1-carboxyl...)
Affinity DataIC50:  334nMAssay Description:Inhibition of human transient receptor potential vanilloid 1 receptor (n=3)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM20284(CHEMBL391997 | CPZ | Capsazepine | N-[2-(4-chlorop...)
Affinity DataIC50:  365nMAssay Description:Inhibition of rat transient receptor potential vanilloid 1 receptor (n=2)More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163228(4-(2-Trifluoromethyl-phenyl)-piperazine-1-carboxyl...)
Affinity DataIC50:  367nMAssay Description:Inhibition of human transient receptor potential vanilloid 1 receptor (n=3)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163220(3-Methyl-3'',4'',5'',6''-tetrahydro-2''H-[2,4'']bi...)
Affinity DataIC50:  390nMAssay Description:Inhibition of rat transient receptor potential vanilloid 1 receptor (n=4)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163218(4-(3-Methyl-pyridin-2-yl)-piperazine-1-carboxylic ...)
Affinity DataIC50:  409nMAssay Description:Inhibition of rat transient receptor potential vanilloid 1 receptor (n=3)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163236(4-(2-Trifluoromethyl-phenyl)-piperazine-1-carboxyl...)
Affinity DataIC50:  526nMAssay Description:Inhibition of human transient receptor potential vanilloid 1 receptor (n=5)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163233(4-(3-Trifluoromethyl-pyridin-2-yl)-[1,4]diazepane-...)
Affinity DataIC50: >538nMAssay Description:Inhibition of human transient receptor potential vanilloid 1 receptor (n=3)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163216(4-(2-Trifluoromethyl-phenyl)-piperazine-1-carboxyl...)
Affinity DataIC50:  605nMAssay Description:Inhibition of rat transient receptor potential vanilloid 1 receptor (n=2)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163222(4-Pyridin-2-yl-piperazine-1-carboxylic acid (4-tri...)
Affinity DataIC50:  863nMAssay Description:Inhibition of rat transient receptor potential vanilloid 1 receptor (n=3)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163242(2,6-Dimethyl-4-(3-trifluoromethyl-pyridin-2-yl)-pi...)
Affinity DataIC50:  908nMAssay Description:Inhibition of rat transient receptor potential vanilloid 1 receptor (n=3)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163219(4-(2-Trifluoromethyl-phenyl)-piperazine-1-carboxyl...)
Affinity DataIC50:  908nMAssay Description:Inhibition of human transient receptor potential vanilloid 1 receptor (n=4)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163239(3''-Trifluoromethyl-3,4,5,6-tetrahydro-2H-[1,2'']b...)
Affinity DataIC50:  965nMAssay Description:Inhibition of human transient receptor potential vanilloid 1 receptor (n=2)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163228(4-(2-Trifluoromethyl-phenyl)-piperazine-1-carboxyl...)
Affinity DataIC50:  1.01E+3nMAssay Description:Inhibition of rat transient receptor potential vanilloid 1 receptor (n=2)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163233(4-(3-Trifluoromethyl-pyridin-2-yl)-[1,4]diazepane-...)
Affinity DataIC50:  1.18E+3nMAssay Description:Inhibition of rat transient receptor potential vanilloid 1 receptor (n=2)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163222(4-Pyridin-2-yl-piperazine-1-carboxylic acid (4-tri...)
Affinity DataIC50:  1.22E+3nMAssay Description:Inhibition of human transient receptor potential vanilloid 1 receptor (n=4)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50163244(3-Trifluoromethyl-3'',4'',5'',6''-tetrahydro-2''H-...)
Affinity DataIC50:  1.31E+3nMAssay Description:Inhibition of human transient receptor potential vanilloid 1 receptor (n=3)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 85 total ) | Next | Last >>
Jump to: